» Articles » PMID: 22342840

A Differentially Methylated Single CpG-site is Correlated with Estrogen Receptor Alpha Transcription

Overview
Date 2012 Feb 21
PMID 22342840
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

DNA methylation of the promoter region of estrogen receptor alpha (ESR1) is recognized as an epigenetic mechanism that regulates its mRNA abundance. We questioned whether tissues in male growing piglets were influenced in terms of DNA methylation by the developmentally occurring distinct plasma estradiol-17β (E2) concentrations. Additionally, we aimed at broadening the currently limited understanding of the epigenetic regulation of ESR1 in physiological settings. Three distinct genetic regions of ESR1 were analyzed using a combination of methylation-sensitive high resolution melting (MS-HRM) and pyrosequencing. Unexpectedly, major E2 concentration differences were only marginally associated with minor variations in DNA methylation and mRNA abundance. However, by analyzing two tissues showing the greatest differences in transcript abundance, we were able to find one single CpG site in the +1kb intragenic region of ESR1 strikingly differently methylated between heart vs. epididymis. Interestingly, this single CpG-site was identified as a putative binding site for the transcriptional repressor TG-interacting factor 1 (TGIF) which can recruit histone deacetylase 1 (HDAC1) leading to chromatin condensation. Indeed, chromatin immunoprecipitation confirmed a reduced histone H3 presence at the specific ESR1 location in case of higher DNA methylation. We therefore hypothesize that ESR1 expression may be manifested by a single-CpG-site based methylation difference impairing transcription factor binding.

Citing Articles

Green forage impacts on the DNA methylation in the ruminal wall of Italian mediterranean dairy buffaloes.

Fioriniello S, Salzano A, Bifulco G, Aiese Cigliano R, Della Ragione F, Campanile G Sci Rep. 2025; 15(1):8074.

PMID: 40057542 PMC: 11890600. DOI: 10.1038/s41598-025-91969-y.


Enhancing health and therapeutic potential: innovations in the medicinal and pharmaceutical properties of soy bioactive compounds.

Rahman U, Younas Z, Ahmad I, Yousaf T, Latif R, Rubab U Front Pharmacol. 2024; 15:1397872.

PMID: 39421675 PMC: 11483366. DOI: 10.3389/fphar.2024.1397872.


The landscape of PBMC methylome in canine mammary tumors reveals the epigenetic regulation of immune marker genes and its potential application in predicting tumor malignancy.

Nam A, Heo M, Lee K, Kim J, Won S, Cho J BMC Genomics. 2023; 24(1):403.

PMID: 37460953 PMC: 10353108. DOI: 10.1186/s12864-023-09471-6.


Enzyme-free targeted DNA demethylation using CRISPR-dCas9-based steric hindrance to identify DNA methylation marks causal to altered gene expression.

Sapozhnikov D, Szyf M Nat Protoc. 2022; 17(12):2840-2881.

PMID: 36207463 DOI: 10.1038/s41596-022-00741-3.


CpG Single-Site Methylation Regulates TLR2 Expression in Proinflammatory PBMCs From Apical Periodontitis Individuals.

Bordagaray M, Fernandez A, Astorga J, Garrido M, Hernandez P, Chaparro A Front Immunol. 2022; 13:861665.

PMID: 35300329 PMC: 8921253. DOI: 10.3389/fimmu.2022.861665.